83
Views
4
CrossRef citations to date
0
Altmetric
Review

Optimal Lipid Modification: The Rationale for Combination Therapy

, &
Pages 317-331 | Published online: 28 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Irina A Pikuleva. (2008) Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering. Expert Opinion on Drug Metabolism & Toxicology 4:11, pages 1403-1414.
Read now
Jonathan Belsey, Simon de Lusignan, Jeremy van Vlymen, Tom Chan & Nigel Hague. (2008) Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy. Current Medical Research and Opinion 24:9, pages 2703-2709.
Read now
Jonathan Belsey, Simon de Lusignan, Tom Chan, Jeremy van Vlymen & Nigel Hague. (2008) Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data. Current Medical Research and Opinion 24:9, pages 2551-2560.
Read now